ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.97A>G (p.Asn33Asp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV002511566 SCV002820965 pathogenic Glanzmann thrombasthenia 2022-11-15 reviewed by expert panel curation The NM_000419.5(ITGA2B):c.97A>G (p.Asn33Asp) missense variant has been reported in four homozygous siblings (patients 2, 4, 6, and 9 PMID:21029361; PM3_supporting). All siblings displayed abnormal bleeding and one sibling tested for platelet aggregation demonstrated impaired response to agonists, with a normal response to ristocetin, which is characteristic of GT. Three of the siblings, including the proband, demonstrated absent platelet αIIbβ3 surface expression measured by flow cytometry (PP4_strong, PP1_strong). In Silico predictor revealed a REVEL score of 0.773, predicting a pathogenic effect (PP3). The variant is not found in gnomAD v2.1.1 (PM2_supporting). In BHK cells transfected with the p.Asn33Asp variant, surface expression of αIIbβ3 was absent (PS3). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive Glanzmann thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_strong, PP1_strong, PP3, PS3, PM2_supporting, and PM3_supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.